Chidamide

Chidamide Structure
CAS No.
743420-02-2
Chemical Name:
Chidamide
Synonyms
CS-1764;Chidamide;HBI-8000);HDAC-IN-7;Chidamide D4;Chidamide(CS055;chidamide analog;Chidamide impurity;Chidamide USP/EP/BP;Tucidinostat (Chidamide)
CBNumber:
CB42590631
Molecular Formula:
C22H19FN4O2
Molecular Weight:
390.41
MOL File:
743420-02-2.mol
MSDS File:
SDS
Modify Date:
2026/7/17 9:03:53

Chidamide Properties

Melting point >145°C (dec.)
Boiling point 600.2±55.0 °C(Predicted)
Density 1.336±0.06 g/cm3(Predicted)
storage temp. 2-8°C(protect from light)
solubility DMSO (Slightly), Methanol (Slightly, Sonicated)
form Solid
pka 12.30±0.70(Predicted)
color Off-White to Pale Beige
InChI InChI=1S/C22H19FN4O2/c23-18-8-9-19(24)20(12-18)27-22(29)17-6-3-16(4-7-17)14-26-21(28)10-5-15-2-1-11-25-13-15/h1-13H,14,24H2,(H,26,28)(H,27,29)
InChIKey WXHHICFWKXDFOW-UHFFFAOYSA-N
SMILES C(NC1=CC(F)=CC=C1N)(=O)C1=CC=C(CNC(=O)C=CC2=CC=CN=C2)C=C1

SAFETY

Risk and Safety Statements

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H315-H319-H335
Precautionary statements  P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501

Chidamide price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Product number Packaging Price Buy

Chidamide Chemical Properties,Uses,Production

Description

Chidamide (Epidaza®), a class I HDAC inhibitor, was discovered and developed by ChipScreen and approved by the CFDA in December 2014 for the treatment of recurrent of refractory peripheral T-cell lymphoma. Chidamide, also known as CS055 and HBI- 8000, is an orally bioavailable benzamide type inhibitor of HDAC isoenzymes class I 1–3, as well as class IIb 10, with potential antineoplastic activity. It selectively binds to and inhibits HDAC, leading to an increase in acetylation levels of histone protein H3.74 This agent also inhibits the expression of signaling kinases in the PI3K/ Akt and MAPK/Ras pathways and may result in cell cycle arrest and the induction of tumor cell apoptosis. Currently, phases I and II clinical trials are underway for the treatment of non-small cell lung cancer and for the treatment of breast cancer, respectively.

Uses

De-5-fluoro 4-Fluorochidamide is an analogue of Chidamide (CAS 743420-02-0), a hitsone deacetylase inhibitor (HDACI) that enhances gemcitabine (G305000) cytotoxicity in pancreatic cancer cells.

Synthesis

The scalable synthetic approach to chidamide very closely follows the discovery route. The sequence began with the condensation of commercial nicotinaldehyde (52) and malonic acid (53) in a mixture of pyridine and piperidine. Next, activation of acid 54 with N,N0-carbonyldiimidazole (CDI) and subsequent reaction with 4-aminomethyl benzoic acid (55) under basic conditions afforded amide 56 in 82% yield. Finally, activation of 56 with CDI prior to treatment with 4-fluorobenzene- 1,2-diamine (57) and subsequent treatment with TFA and THF yielded chidamide (VIII) in 38% overall yield from 52. However, no publication reported that mono-N-Boc-protected bis-aniline was used to approach Chidamide.

Synthesis_743420-02-2

Chidamide Preparation Products And Raw materials

Global( 158)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6094 58 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32997 60 Inquiry
career henan chemical co +86-0371-86658258 China 29765 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354; +1-00000000000 United States 32431 58 Inquiry
Win-Win chemical CO., Limited +86-0086-577-64498589 +86-15355981851 China 14297 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 29086 58 Inquiry
BOC Sciences 16314854226; +8616314854226 United States 19852 58 Inquiry
InvivoChem +1-708-310-1919 +1-13798911105 United States 6378 58 Inquiry
Coresyn Pharmatech Co., Ltd. +86-571-86626709 +86-18157142896 China 9976 58 Inquiry
Nantong HI-FUTURE Biology Co., Ltd. +86-18051384581 China 3123 58 Inquiry
(E)-N-(2-amino-5-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide Chidamide Chidamide (E)-N-(2-aMino-5-fluorophenyl)-4-((3-(pyridin-3-yl)acrylaMido)Methyl)benzaMide N-(2-Amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propenyl]amino]methyl]benzamide De-4-fluoro 5-Fluoro Chidamide CHIDAMIDE;(E)-N-(2-AMINO-5-FLUOROPHENYL)-4-((3-(PYRIDIN-3-YL)ACRYLAMIDO)METHYL)BENZAMIDE;(E)-N-(2-AMINO-5-FLUOROPHENYL)-4-((3-(PYRIDIN-3-YL)ACRYLAMIDO)METHYL)BENZAMIDE CHIDAMIDE;N-(2-AMINO-5-FLUOROPHENYL)-4-[[[1-OXO-3-(3-PYRIDINYL)-2-PROPENYL]AMINO]METHYL N-(2-Amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propenyl]amino]methyl Chidamide D4 Tucidinostat (Chidamide) chidamide analog Chidamide(CS055 CS-1764 HBI-8000) Chidamide,HBI-8000, CS-055, >96% Chidamide impurity HDAC-IN-7 Benzamide, N-(2-amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]- Chidamide,HBI-8000, CS-055 Chidamide USP/EP/BP N-(2-Amino-5-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide Benzamide,N-(2-amino-5-fluorophenyl)-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl] N - (2-amino-5-fluorophenyl) -4- ((3- (pyridin-3-yl) acrylamide) methyl) benzamide HDAC-IN-7, 10 mM in DMSO N-(2-Amino-5-fluorophenyl)-4-(N-(3-pyridineacryloyl)aminomethyl)benzamide 743420-02-2 Inhibitors API